These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 30716477)
1. No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study. Dong J; Gharahkhani P; Chow WH; Gammon MD; Liu G; Caldas C; Wu AH; Ye W; Onstad L; Anderson LA; Bernstein L; Pharoah PD; Risch HA; Corley DA; Fitzgerald RC; ; Iyer PG; Reid BJ; Lagergren J; Shaheen NJ; Vaughan TL; MacGregor S; Love S; Palles C; Tomlinson I; Gockel I; May A; Gerges C; Anders M; Böhmer AC; Becker J; Kreuser N; Thieme R; Noder T; Venerito M; Veits L; Schmidt T; Schmidt C; Izbicki JR; Hölscher AH; Lang H; Lorenz D; Schumacher B; Mayershofer R; Vashist Y; Ott K; Vieth M; Weismüller J; Nöthen MM; Moebus S; Knapp M; Peters WHM; Neuhaus H; Rösch T; Ell C; Jankowski J; Schumacher J; Neale RE; Whiteman DC; Thrift AP Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2227-2235.e1. PubMed ID: 30716477 [TBL] [Abstract][Full Text] [Related]
2. Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants. Dong J; Buas MF; Gharahkhani P; Kendall BJ; Onstad L; Zhao S; Anderson LA; Wu AH; Ye W; Bird NC; Bernstein L; Chow WH; Gammon MD; Liu G; Caldas C; Pharoah PD; Risch HA; Iyer PG; Reid BJ; Hardie LJ; Lagergren J; Shaheen NJ; Corley DA; Fitzgerald RC; ; Whiteman DC; Vaughan TL; Thrift AP Gastroenterology; 2018 Apr; 154(5):1273-1281.e3. PubMed ID: 29247777 [TBL] [Abstract][Full Text] [Related]
3. Obesity and risk of esophageal adenocarcinoma and Barrett's esophagus: a Mendelian randomization study. Thrift AP; Shaheen NJ; Gammon MD; Bernstein L; Reid BJ; Onstad L; Risch HA; Liu G; Bird NC; Wu AH; Corley DA; Romero Y; Chanock SJ; Chow WH; Casson AG; Levine DM; Zhang R; Ek WE; MacGregor S; Ye W; Hardie LJ; Vaughan TL; Whiteman DC J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25269698 [TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of Genes Related to Function and Metabolism of Vitamin D in Esophageal Adenocarcinoma. Singhal S; Kapoor H; Subramanian S; Agrawal DK; Mittal SK J Gastrointest Cancer; 2019 Dec; 50(4):867-878. PubMed ID: 30187205 [TBL] [Abstract][Full Text] [Related]
5. Risk of esophageal adenocarcinoma decreases with height, based on consortium analysis and confirmed by Mendelian randomization. Thrift AP; Risch HA; Onstad L; Shaheen NJ; Casson AG; Bernstein L; Corley DA; Levine DM; Chow WH; Reid BJ; Romero Y; Hardie LJ; Liu G; Wu AH; Bird NC; Gammon MD; Ye W; Whiteman DC; Vaughan TL Clin Gastroenterol Hepatol; 2014 Oct; 12(10):1667-76.e1. PubMed ID: 24530603 [TBL] [Abstract][Full Text] [Related]
6. Serum 25-Hydroxyvitamin D Levels and the Risk of Dysplasia and Esophageal Adenocarcinoma in Patients with Barrett's Esophagus. Thota PN; Kistangari G; Singh P; Cummings L; Hajifathalian K; Lopez R; Sanaka MR Dig Dis Sci; 2016 Jan; 61(1):247-54. PubMed ID: 26233550 [TBL] [Abstract][Full Text] [Related]
7. Predicting the potential deterioration of Barrett's esophagus based on gut microbiota: a Mendelian randomization analysis. Li C; Shu P; Shi T; Chen Y; Mei P; Zhang Y; Wang Y; Du X; Wang J; Zhang Y; Liu B; Sheng Z; Chan S; Dan Z Mamm Genome; 2024 Sep; 35(3):399-413. PubMed ID: 38886201 [TBL] [Abstract][Full Text] [Related]
8. Association Between Levels of Sex Hormones and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus. Xie SH; Fang R; Huang M; Dai J; Thrift AP; Anderson LA; Chow WH; Bernstein L; Gammon MD; Risch HA; Shaheen NJ; Reid BJ; Wu AH; Iyer PG; Liu G; Corley DA; Whiteman DC; Caldas C; Pharoah PD; Hardie LJ; Fitzgerald RC; Shen H; Vaughan TL; Lagergren J Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2701-2709.e3. PubMed ID: 31756444 [TBL] [Abstract][Full Text] [Related]
9. Germline variation in the insulin-like growth factor pathway and risk of Barrett's esophagus and esophageal adenocarcinoma. Dighe SG; Chen J; Yan L; He Q; Gharahkhani P; Onstad L; Levine DM; Palles C; Ye W; Gammon MD; Iyer PG; Anderson LA; Liu G; Wu AH; Dai JY; Chow WH; Risch HA; Lagergren J; Shaheen NJ; Bernstein L; Corley DA; Prenen H; deCaestecker J; MacDonald D; Moayyedi P; Barr H; Love SB; Chegwidden L; Attwood S; Watson P; Harrison R; Ott K; Moebus S; Venerito M; Lang H; Mayershofer R; Knapp M; Veits L; Gerges C; Weismüller J; Gockel I; Vashist Y; Nöthen MM; Izbicki JR; Manner H; Neuhaus H; Rösch T; Böhmer AC; Hölscher AH; Anders M; Pech O; Schumacher B; Schmidt C; Schmidt T; Noder T; Lorenz D; Vieth M; May A; Hess T; Kreuser N; Becker J; Ell C; Ambrosone CB; Moysich KB; MacGregor S; Tomlinson I; Whiteman DC; Jankowski J; Schumacher J; Vaughan TL; Madeleine MM; Hardie LJ; Buas MF Carcinogenesis; 2021 Apr; 42(3):369-377. PubMed ID: 33300568 [TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in genes in the androgen pathway and risk of Barrett's esophagus and esophageal adenocarcinoma. Ek WE; Lagergren K; Cook M; Wu AH; Abnet CC; Levine D; Chow WH; Bernstein L; Risch HA; Shaheen NJ; Bird NC; Corley DA; Hardie LJ; Fitzgerald RC; Gammon MD; Romero Y; Liu G; Ye W; Vaughan TL; MacGregor S; Whiteman DC; Westberg L; Lagergren J Int J Cancer; 2016 Mar; 138(5):1146-52. PubMed ID: 26414697 [TBL] [Abstract][Full Text] [Related]
11. Genes of the interleukin-18 pathway are associated with susceptibility to Barrett's esophagus and esophageal adenocarcinoma. Babar M; Ryan AW; Anderson LA; Segurado R; Turner G; Murray LJ; Murphy SJ; Johnston BT; Comber H; Reynolds JV; McManus R Am J Gastroenterol; 2012 Sep; 107(9):1331-41. PubMed ID: 22664470 [TBL] [Abstract][Full Text] [Related]
12. Phase I and II enzyme polymorphisms as risk factors for Barrett's esophagus and esophageal adenocarcinoma: a systematic review and meta-analysis. Bull LM; White DL; Bray M; Nurgalieva Z; El-Serag HB Dis Esophagus; 2009; 22(7):571-87. PubMed ID: 19222528 [TBL] [Abstract][Full Text] [Related]
13. A population-based association study of SNPs of GSTP1, MnSOD, GPX2 and Barrett's esophagus and esophageal adenocarcinoma. Murphy SJ; Hughes AE; Patterson CC; Anderson LA; Watson RG; Johnston BT; Comber H; McGuigan J; Reynolds JV; Murray LJ Carcinogenesis; 2007 Jun; 28(6):1323-8. PubMed ID: 17277236 [TBL] [Abstract][Full Text] [Related]
14. Leukocyte telomere length in relation to the risk of Barrett's esophagus and esophageal adenocarcinoma. Wennerström EC; Risques RA; Prunkard D; Giffen C; Corley DA; Murray LJ; Whiteman DC; Wu AH; Bernstein L; Ye W; Chow WH; Vaughan TL; Liao LM Cancer Med; 2016 Sep; 5(9):2657-65. PubMed ID: 27384379 [TBL] [Abstract][Full Text] [Related]
15. A newly identified susceptibility locus near FOXP1 modifies the association of gastroesophageal reflux with Barrett's esophagus. Dai JY; de Dieu Tapsoba J; Buas MF; Onstad LE; Levine DM; Risch HA; Chow WH; Bernstein L; Ye W; Lagergren J; Bird NC; Corley DA; Shaheen NJ; Wu AH; Reid BJ; Hardie LJ; Whiteman DC; Vaughan TL Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1739-47. PubMed ID: 26377193 [TBL] [Abstract][Full Text] [Related]
16. Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis. Gharahkhani P; Fitzgerald RC; Vaughan TL; Palles C; Gockel I; Tomlinson I; Buas MF; May A; Gerges C; Anders M; Becker J; Kreuser N; Noder T; Venerito M; Veits L; Schmidt T; Manner H; Schmidt C; Hess T; Böhmer AC; Izbicki JR; Hölscher AH; Lang H; Lorenz D; Schumacher B; Hackelsberger A; Mayershofer R; Pech O; Vashist Y; Ott K; Vieth M; Weismüller J; Nöthen MM; ; ; ; Attwood S; Barr H; Chegwidden L; de Caestecker J; Harrison R; Love SB; MacDonald D; Moayyedi P; Prenen H; Watson RGP; Iyer PG; Anderson LA; Bernstein L; Chow WH; Hardie LJ; Lagergren J; Liu G; Risch HA; Wu AH; Ye W; Bird NC; Shaheen NJ; Gammon MD; Corley DA; Caldas C; Moebus S; Knapp M; Peters WHM; Neuhaus H; Rösch T; Ell C; MacGregor S; Pharoah P; Whiteman DC; Jankowski J; Schumacher J Lancet Oncol; 2016 Oct; 17(10):1363-1373. PubMed ID: 27527254 [TBL] [Abstract][Full Text] [Related]
17. Exploring the Impact of Antireflux Treatment on Risk of Esophageal Adenocarcinoma in Patients With Barrett's Esophagus: Insights from a Mendelian Randomization Study. Li Z; Yang K Gastroenterology; 2024 May; 166(5):944-945. PubMed ID: 38246505 [No Abstract] [Full Text] [Related]
18. Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia. Parasa S; Vennalaganti S; Gaddam S; Vennalaganti P; Young P; Gupta N; Thota P; Cash B; Mathur S; Sampliner R; Moawad F; Lieberman D; Bansal A; Kennedy KF; Vargo J; Falk G; Spaander M; Bruno M; Sharma P Gastroenterology; 2018 Apr; 154(5):1282-1289.e2. PubMed ID: 29273452 [TBL] [Abstract][Full Text] [Related]
19. Chromosomal abnormalities and novel disease-related regions in progression from Barrett's esophagus to esophageal adenocarcinoma. Akagi T; Ito T; Kato M; Jin Z; Cheng Y; Kan T; Yamamoto G; Olaru A; Kawamata N; Boult J; Soukiasian HJ; Miller CW; Ogawa S; Meltzer SJ; Koeffler HP Int J Cancer; 2009 Nov; 125(10):2349-59. PubMed ID: 19670330 [TBL] [Abstract][Full Text] [Related]
20. Interactions Between Genetic Variants and Environmental Factors Affect Risk of Esophageal Adenocarcinoma and Barrett's Esophagus. Dong J; Levine DM; Buas MF; Zhang R; Onstad L; Fitzgerald RC; ; Corley DA; Shaheen NJ; Lagergren J; Hardie LJ; Reid BJ; Iyer PG; Risch HA; Caldas C; Caldas I; Pharoah PD; Liu G; Gammon MD; Chow WH; Bernstein L; Bird NC; Ye W; Wu AH; Anderson LA; MacGregor S; Whiteman DC; Vaughan TL; Thrift AP Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1598-1606.e4. PubMed ID: 29551738 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]